BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38861415)

  • 41. A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.
    Guo C; Liu Y; Yang H; Xia Y; Li X; Chen L; Feng Y; Zhang Y; Chen Y; Huang Z
    Br J Radiol; 2024 Mar; 97(1156):859-867. PubMed ID: 38290775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [
    Wang Y; Luo W; Li Y
    Eur J Med Res; 2023 Jan; 28(1):34. PubMed ID: 36653862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [
    Wu C; Zhang X; Zeng Y; Wu R; Ding L; Xia Y; Chen Z; Zhang X; Wang X
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):194-204. PubMed ID: 36040490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different Uptake of
    Wu M; Pan Q; Luo Y
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 68 Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma : Comparison With 18 F-FDG PET/CT and Abdominal 68 Ga-FAPI-04 PET/MR.
    Zhang Z; Cheng C; Jiang H; Pan G; Yu Y; Jin G; Zuo C
    Clin Nucl Med; 2024 May; 49(5):409-418. PubMed ID: 38465929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [
    Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
    Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Superiority of FAPI-PET/CT for examining multiple malignant tumors: a retrospective study.
    Li W; Jiang Z; Cui N; Li J; Cheng L; Liu W; Li J; Wang K
    Am J Cancer Res; 2023; 13(10):4547-4559. PubMed ID: 37970338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Head-to-head Intra-individual Comparison of [
    Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
    Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
    Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Value of Semi-Quantitative Parameters of
    Li T; Liu Y; Dai M; Zhao X; Han J; Zhang Z; Jing F; Tian W; Zhang J; Zhao X; Wang J; Hao T; Wang T
    Cancer Biother Radiopharm; 2024 May; ():. PubMed ID: 38808470
    [No Abstract]   [Full Text] [Related]  

  • 53. Head‑to‑head assessment of [
    Zhang A; Meng X; Yao Y; Zhou X; Zhang Y; Li N
    Eur J Radiol; 2022 Oct; 155():110507. PubMed ID: 36075176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans.
    Wu J; Zhang S; Rao Z; Wang Y; Zhang C
    Clin Nucl Med; 2022 Jul; 47(7):629-631. PubMed ID: 35452009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT.
    Nourbakhsh S; Salehi Y; Farzanehfar S; Ghaletaki R; Bakhshi Kashi M; Abbasi M
    Nuklearmedizin; 2024 Jan; ():. PubMed ID: 38190996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Diagnostic Efficacy of [
    Zhang S; Wang W; Xu T; Ding H; Li Y; Liu H; Huang Y; Liu L; Du T; Zhao Y; Chen Y; Qiu L
    Front Oncol; 2022; 12():925100. PubMed ID: 35847877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Added Value of
    Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
    J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of PET imaging of activated fibroblasts and
    Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 68Ga-FAPI PET/CT Detected Non-FDG-Avid Gastric Stromal Tumor.
    Qiu L; Lan L; Liu H; Deng J; Chen Y
    Clin Nucl Med; 2022 Mar; 47(3):226-227. PubMed ID: 34392281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.